Experts say there’s no set number of hours, but quality, relevance and ongoing support — returning to the same skills ...

AC Immune receives a "Buy" rating, driven by positive phase 2 VacSYn trial results for ACI-7104.056 in early Parkinson's ...

A combination of the antibody-drug conjugate enfortumab vedotin (Padcev) and the PD-1 inhibitor pembrolizumab (Keytruda) ...

Holiday health tips to avoid weight gain, fatigue, stress, and infections. Learn simple ways to eat smart, sleep well, stay active, and protect immunity this festive season.

The TBCRC-056 trial showed a 50% pCR rate in TNBC patients with BRCA or PALB2 mutations treated with niraparib and dostarlimab. sTILs increased significantly in both treatment arms, with higher ...

AC Immune Positive Interim Phase 2 Data on ACI-7104.056 Support Potential Slowing of Progression of Parkinson’s DiseaseResults show, for the ...

"I hate it, it's turned my life upside down," says Hannah Dickerson about how her life has changed since being diagnosed with ...

A study of more than 1 million UK medical records found that getting a flu vaccine between ages 40 and 50 did not increase Parkinson’s disease risk and was even associated with a lower estimated ...

Investing.com -- AC Immune (NASDAQ:ACIU) stock rose 25% after the company reported positive interim Phase 2 data for its Parkinson’s disease treatment, suggesting the therapy may slow disease ...

Beyond common myths, coffee can be a strong ally for your well-being. Discover what science says and how to drink it without ...

People with hidden conditions including heart disease, dementia, ADHD, epilepsy, chronic fatigue or Parkinson's may be ...

Sweat is no longer just about workouts. With AI and smart sensors, it could help detect diabetes, stress and even early signs ...